Subependymal Giant Cell Astrocytoma

• CLINICAL_TRIALS trial_result · 2019-04-25
  Clinical Trial Update: Everolimus in Treating Patients With Recurrent Low-Grade Glioma [Phase 2]

  Phase 2 clinical trial of everolimus in adults with recurrent low-grade glioma has completed; results were posted in 2019.

• CLINICAL_TRIALS trial_result · 2015-06-15
  Clinical Trial Update: Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma [Phase 1, Phase 2]

  This entry reports the completion and posted results of a Phase 1/2 trial evaluating erlotinib in combination with temsirolimus for recurren…

• CLINICAL_TRIALS trial_result · 2015-03-23
  Clinical Trial Update: Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or Ependymoma [Phase 2]

  Phase 2 trial of sunitinib malate in children with recurrent, refractory, or progressive malignant gliomas and ependymomas has completed; re…

• CLINICAL_TRIALS trial_result · 2014-10-20
  Clinical Trial Update: Everolimus (RAD001) Therapy of Giant Cell Astrocytoma in Patients With Tuberous Sclerosis Complex [Phase 1, Phase 2]

  This clinical trial update reports results for everolimus (RAD001) therapy of giant cell astrocytoma in patients with tuberous sclerosis com…

• CLINICAL_TRIALS trial_result · 2012-05-01
  Clinical Trial Update: Efficacy and Safety of Everolimus (RAD001) in Patients of All Ages With Subependymal Giant Cell Astrocytoma Associated With Tuberous Sclerosis Complex (TSC)(EXIST-1) [Phase 3]

  Phase 3 EXIST-1 trial evaluating everolimus for subependymal giant cell astrocytoma in tuberous sclerosis complex demonstrates efficacy and …

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.